{
    "clinical_study": {
        "@rank": "67328", 
        "arm_group": [
            {
                "arm_group_label": "Triamcinolone", 
                "arm_group_type": "Active Comparator", 
                "description": "kortikosteroid"
            }, 
            {
                "arm_group_label": "5-fluorouracil", 
                "arm_group_type": "Active Comparator", 
                "description": "antimitotic drug"
            }
        ], 
        "brief_summary": {
            "textblock": "The aim of study is examine the efficacy of intralesional 5-fluorouracil injections in\n      keloid disease treatment."
        }, 
        "brief_title": "Treatment of Keloidscars With Intralesional Triamcinolone and 5-fluorouracil Injections-prospective, Randomized, Controlled Trial - Pilot Study", 
        "completion_date": {
            "#text": "December 2016", 
            "@type": "Anticipated"
        }, 
        "condition": "Keloidscars", 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Person who has a keloidscar which could be treated with injection treatment\n\n        Exclusion Criteria:\n\n          -  Pregnancy, lactating, renal or liver failure"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "50", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "April 9, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02155439", 
            "org_study_id": "140260M", 
            "secondary_id": "2013-004512-22"
        }, 
        "intervention": [
            {
                "arm_group_label": "Triamcinolone", 
                "description": "antimitotic drug", 
                "intervention_name": "5-fluorouracil", 
                "intervention_type": "Drug", 
                "other_name": "Fluorouracil Accord"
            }, 
            {
                "arm_group_label": "5-fluorouracil", 
                "intervention_name": "Triamcinolone", 
                "intervention_type": "Drug", 
                "other_name": "Lederspan"
            }
        ], 
        "intervention_browse": {
            "mesh_term": [
                "Antimitotic Agents", 
                "Fluorouracil", 
                "Triamcinolone Acetonide", 
                "Triamcinolone hexacetonide", 
                "Triamcinolone", 
                "Triamcinolone diacetate"
            ]
        }, 
        "is_fda_regulated": "No", 
        "keyword": "Prospective, randomized controlled trial - pilot study", 
        "lastchanged_date": "June 2, 2014", 
        "location": {
            "contact": {
                "email": "kristiina.hietanen@pshp.fi", 
                "last_name": "Kristiina E Hietanen", 
                "phone": "+358331165881"
            }, 
            "facility": {
                "address": {
                    "city": "Tampere", 
                    "country": "Finland", 
                    "zip": "33521"
                }, 
                "name": "Tampere university hospital"
            }, 
            "investigator": {
                "last_name": "Kristiina E Hietanen, ms", 
                "role": "Principal Investigator"
            }, 
            "status": "Not yet recruiting"
        }, 
        "location_countries": {
            "country": "Finland"
        }, 
        "number_of_arms": "2", 
        "official_title": "Treatment of Keloidscars With Intralesional Triamcinolone and 5-fluorouracil Injections-prospective, Randomized, Controlled Trial - Pilot Study", 
        "other_outcome": {
            "description": "immonuhistochemical analysis with punch biopsy", 
            "measure": "Inflammatory cells and their different populations, blood vessel density, fibroplast proliferation (KI67) and estrogenreseptor", 
            "safety_issue": "Yes", 
            "time_frame": "0 week, 3 week, 6 week, 12 week, 1 year"
        }, 
        "overall_contact": {
            "email": "kristiina.hietanen@pshp.fi", 
            "last_name": "Kristiina E Hietanen", 
            "phone": "+358331169469"
        }, 
        "overall_status": "Not yet recruiting", 
        "oversight_info": {
            "authority": "Finland: Ministry of Social Affairs and Health", 
            "has_dmc": "Yes"
        }, 
        "phase": "Phase 4", 
        "primary_completion_date": {
            "#text": "December 2016", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "Change from baseline symptoms of scars baseline at one year with POSAS score", 
            "measure": "Symptoms (pain, itching) of keloids and appearance of keloid", 
            "safety_issue": "No", 
            "time_frame": "baseline and one year"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02155439"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Tampere University Hospital", 
            "investigator_full_name": "Kristiina Hietanen", 
            "investigator_title": "MD", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": {
            "description": "Camera analysis with spectrocutometry", 
            "measure": "Concentration change of hemoglobin and melanin", 
            "safety_issue": "No", 
            "time_frame": "0 week, 3 week, 6 week, 12 week, 1 year"
        }, 
        "source": "Tampere University Hospital", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Tampere University Hospital", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "May 2014", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator, Outcomes Assessor), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "April 2014"
    }
}